2022
DOI: 10.1111/apt.16977
|View full text |Cite
|
Sign up to set email alerts
|

Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID‐19 pandemic—authors’ reply

Abstract: The authors noted that recent data by Ricciuto et al. have found acute severe IBD to be associated with severe COVID-19 disease outcomes. 3 ICU/ventilation/death in IBD sub-cohorts with remission, moderate disease and severe IBD was 3.6%, 4.9% and 8.8%, respectively. We beg to differ with the authors that these rates are different to those observed in our cohort. Critical care need in patients with IBD was 3.36% in our cohort and in IBD patients with recent steroid use was 7.97%. These patients likely represen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 3 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?